Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 157,383 | 163,620 | 153,679 | 131,774 | 175,220 |
| Marketable Securities | 312,098 | 365,416 | 435,180 | 280,781 | 282,023 |
| Receivables | 9,519 | 7,140 | 5,224 | 1,633 | 783 |
| Inventories | 3,881 | 4,175 | 4,301 | 2,867 | N/A |
| TOTAL | $489,753 | $547,897 | $603,490 | $423,897 | $462,352 |
| Non-Current Assets | |||||
| PPE Net | 3,471 | 3,081 | 3,159 | 2,897 | 2,623 |
| Intangibles | 6,646 | 7,015 | 7,385 | 7,754 | 0 |
| Other Non-Current Assets | 3,143 | 3,160 | 3,350 | 3,486 | 1,615 |
| TOTAL | $13,260 | $13,256 | $13,894 | $14,137 | $4,238 |
| Total Assets | $503,013 | $561,153 | $617,384 | $438,034 | $466,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,166 | 3,912 | 2,828 | 1,024 | 1,307 |
| Accrued Expenses | 38,967 | 36,029 | 34,445 | 27,485 | 19,815 |
| TOTAL | $45,265 | $42,585 | $39,149 | $29,022 | $21,122 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 157 | N/A | 197 | 217 |
| Deferred Revenues | 4,132 | 2,644 | 1,876 | 513 | N/A |
| Other Non-Current Liabilities | 224 | 0 | 177 | 0 | 0 |
| TOTAL | $224 | $157 | $177 | $197 | $217 |
| Total Liabilities | $45,489 | $42,742 | $39,326 | $29,219 | $21,339 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,046 | 121,408 | 121,114 | 114,006 | 113,163 |
| Common Shares | 12 | 12 | 12 | 11 | 11 |
| Retained earnings | -1,022,112 | -933,979 | -855,283 | -783,670 | -712,348 |
| Other shareholders' equity | 94 | 106 | 533 | 206 | 316 |
| TOTAL | $457,524 | $518,411 | $578,058 | $408,815 | $445,251 |
| Total Liabilities And Equity | $503,013 | $561,153 | $617,384 | $438,034 | $466,590 |